FDA Inspection
Calyx Chemicals & Pharmaceuticals LimitedCalyx Chemicals & Pharmaceuticals Limited – FDA Inspection, May 17, 2024
Record Details
This FDA Inspection record concerns Calyx Chemicals & Pharmaceuticals Limited, with an inspection on May 17, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 0e4db988-4bbb-42d5-a17d-9901226c1dca
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1240456
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Calyx Chemicals & Pharmaceuticals Limited
4| Date | Classification | Office | Project area |
|---|---|---|---|
| November 8, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 4, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 27, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 18, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Calyx Chemicals & Pharmaceuticals Limited
- FDA Inspection 1110153 - 2019-11-08
- FDA Inspection 967429 - 2016-03-04
- FDA Inspection 775620 - 2012-03-27
- FDA Inspection 641001 - 2009-09-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.